Myocardial InfarctionDisease Models, AnimalCardiovascular DiseasesMesenchymal Stem Cell TransplantationInjectionsMyocardiumVentricular RemodelingMyocytes, CardiacNeovascularization, PhysiologicStem Cell TransplantationEchocardiographyMesenchymal Stromal CellsRats, Sprague-DawleyRisk FactorsTreatment OutcomeInfarctionTime FactorsElectrocardiographyProspective StudiesCerebral InfarctionAngioplasty, Balloon, CoronaryThrombolytic TherapyCoronary AngiographyFollow-Up StudiesAnterior Wall Myocardial InfarctionMyocardial ReperfusionRisk AssessmentPrognosisCohort StudiesBiological MarkersPredictive Value of TestsCoronary DiseaseRetrospective StudiesStreptokinaseDogsCreatine KinaseProportional Hazards ModelsIncidenceSwineGenetic TherapyOutcome Assessment (Health Care)Ventricular Function, LeftFibrinolytic AgentsStrokeCoronary Artery DiseaseCoronary Care UnitsPlatelet Aggregation InhibitorsAngina PectorisMyocardial IschemiaRecurrenceMultivariate AnalysisAngina, UnstableAge FactorsStentsHospital MortalityHypertensionCoronary VesselsMyocardial RevascularizationRiskCase-Control StudiesHeart FailureAcute DiseaseSurvival AnalysisRegistriesVentricular Dysfunction, LeftCoronary ThrombosisSex FactorsStroke VolumePercutaneous Coronary InterventionLogistic ModelsBlood PressureUnited StatesAspirinCoronary CirculationShock, CardiogenicHeartRandomized Controlled Trials as TopicCardiovascular AgentsSurvival RateInferior Wall Myocardial InfarctionHospitalizationCoronary Artery BypassDiabetes ComplicationsOdds RatioChest PainChi-Square DistributionDiabetes MellitusSeverity of Illness IndexKaplan-Meier EstimateAcute Coronary SyndromeHeart VentriclesCause of DeathRegression AnalysisC-Reactive ProteinArrhythmias, CardiacAtherosclerosisPrevalenceDouble-Blind MethodTissue Plasminogen ActivatorSmoking